{"transactions":[{"id":986506,"issuer":{"id":8244,"kind":"organization","name":"Kairos Pharma, LTD."},"owners":[{"id":72498,"kind":"person","name":"Samuelson Doug","position":1,"cik":"0001943326","reported_name":"Samuelson Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2025-11-26T17:24:13.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":152672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 152,672 restricted stock units (\"RSUs\") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 152,672 RSUs are scheduled to vest in full on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (1) 140,367 shares of common stock and (2) 152,672 RSUs which remain subject to vesting."}],"balance_after":293039,"source":{"system":"sec-edgar","filing":"0001493152-25-025198","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1943326/000149315225025198/ownership.xml","form_type":"4"}},{"id":1352275,"issuer":{"id":8244,"kind":"organization","name":"Kairos Pharma, LTD."},"owners":[{"id":72498,"kind":"person","name":"Samuelson Doug","position":1,"cik":"0001943326","reported_name":"Samuelson Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2024-11-25T06:03:39.000Z","date":"2024-11-22","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.5,"value":3750.0,"ownership":{"direct":true},"balance_after":60796,"source":{"system":"sec-edgar","filing":"0001493152-24-047526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1943326/000149315224047526/ownership.xml","form_type":"4"}},{"id":1408273,"issuer":{"id":8169,"kind":"organization","name":"Newton Golf Company, Inc."},"owners":[{"id":72498,"kind":"person","name":"Samuelson Doug","position":1,"cik":"0001943326","reported_name":"Samuelson Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Purchase Common Stock","published_at":"2024-09-12T21:56:31.000Z","date":"2024-09-09","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective September 9, 2024, the reporting person was granted options to purchase an aggregate of 36,000 shares vesting as follows: 1/3 of the options will vest 12 months after the vesting commencement date and 1/36th of the total shares will vest at the end of each month thereafter until the options are fully vested or the reporting person's continuous service terminates, whichever occurs first. The exercise price of the options is $3.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective September 9, 2024, the reporting person was granted options to purchase an aggregate of 36,000 shares vesting as follows: 1/3 of the options will vest 12 months after the vesting commencement date and 1/36th of the total shares will vest at the end of each month thereafter until the options are fully vested or the reporting person's continuous service terminates, whichever occurs first. The exercise price of the options is $3.00 per share."}],"balance_after":36000,"derivative":{"exercise_price":3,"exercise_date":"2024-09-09","expiration_date":"2031-09-09","underlying":"Common","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001493152-24-036096","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1934245/000149315224036096/ownership.xml","form_type":"4"}},{"id":1782796,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":72498,"kind":"person","name":"Samuelson Doug","position":1,"cik":"0001943326","reported_name":"Samuelson Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-12T20:25:20.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest on September 11, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":40000,"derivative":{"exercise_price":22.4,"expiration_date":"2033-09-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-049103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049103/doc4.xml","form_type":"4"}},{"id":1799542,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":72498,"kind":"person","name":"Samuelson Doug","position":1,"cik":"0001943326","reported_name":"Samuelson Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-22T20:17:20.000Z","date":"2023-08-18","kind":"sale","planned":false,"acquired":false,"shares":1297,"price":23.73,"value":30777.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $23.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":2303,"source":{"system":"sec-edgar","filing":"0001209191-23-046885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123046885/doc4.xml","form_type":"4"}},{"id":1908082,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":72498,"kind":"person","name":"Samuelson Doug","position":1,"cik":"0001943326","reported_name":"Samuelson Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-02T20:23:53.000Z","date":"2023-02-17","kind":"grant","planned":false,"acquired":true,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of common stock upon vesting.  The RSUs will be fully vested on July 25, 2023."}],"balance_after":3600,"source":{"system":"sec-edgar","filing":"0001209191-23-026491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123026491/doc4.xml","form_type":"4"}}]}